1 Min Read
March 20 (Reuters) - Glenmark Pharmaceuticals Ltd
* Says Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod capsules, 0.5 mg Source text: bit.ly/2nciKQ2 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.